Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2020 | Exciting updates from SABCS 2020

Sibylle Loibl • 10 Dec 2020
SABCS 2020
Breast Cancer
MONALEESA monarchE

Sibylle Loibl, MD, PhD, German Breast Group, Neu-Isenburg, Germany, outlines exciting updates presented at this years’ San Antonio Breast Cancer Symposium (SABCS) including the results of the monarchE study (NCT02107703) as well as combined analysis of the MONALEESA study (NCT01958021). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Sibylle Loibl

Long-term survival of the Phase II GeparOLA study
1:28
Long-term survival of the Phase II GeparOLA study
Sibylle Loibl • 6 Dec 2022
Maintenance w/ ET + ribociclib after 1L chemotherapy in HR+/HER2- metastatic breast cancer
0:36
Maintenance w/ ET + ribociclib after 1L chemotherapy in HR+/HER2- metastatic breast cancer
Sibylle Loibl • 6 Dec 2022
Composite biomarkers predictive of palbociclib + endocrine treatment benefit in early breast cancer
1:43
Composite biomarkers predictive of palbociclib + endocrine treatment benefit in early breast cancer
Sibylle Loibl • 6 Dec 2022
Key takeaways from SABCS 2022
1:03
Key takeaways from SABCS 2022
Sibylle Loibl • 6 Dec 2022

Related Videos

How will SARMs fit into the current breast cancer treatment paradigm?
1:14
How will SARMs fit into the current breast cancer treatment paradigm?
Rafael Grochot • 2 Jul 2026
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
1:35
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
Rafael Grochot • 2 Jul 2026
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
1:07
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
Sanjoy Chatterjee • 17 May 2026
Design and aim of the HYPORT study in regional nodal breast cancer
1:23
Design and aim of the HYPORT study in regional nodal breast cancer
Sanjoy Chatterjee • 17 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals